  Osteoarthritis ( OA) is a leading cause of physical disability among aging populations , with no available drugs able to efficiently restore the balance<symptom> between cartilage matrix synthesis and degradation. Also , OA has not been accurately classified into subpopulations , hindering the development toward personalized precision medicine. In the present study , we identified a subpopulation of OA patients displaying high activation level of epidermal growth factor receptor ( EGFR). With Col2a1-creER